Short answer · Medically reviewed summary · Last updated: 2026-05-08
Currently, there is no cure for Multiple Systems Atrophy (MSA), so treatment focuses exclusively on managing symptoms to maintain quality of life. Clinical management for Multiple Systems Atrophy typically involves a combination of medication for motor and autonomic dysfunction, alongside physical and occupational therapy to manage physical limitations. What are the primary medical treatments for Multiple Systems Atrophy? Treatment for Multiple Systems Atrophy must be highly personalized, as symptoms vary significantly between individuals.
6 people with Multiple Systems Atrophy have shared their first-person experience on this question at DiseaseMaps.
Currently, there is no cure for Multiple Systems Atrophy (MSA), so treatment focuses exclusively on managing symptoms to maintain quality of life. Clinical management for Multiple Systems Atrophy typically involves a combination of medication for motor and autonomic dysfunction, alongside physical and occupational therapy to manage physical limitations.
Treatment for Multiple Systems Atrophy must be highly personalized, as symptoms vary significantly between individuals. Physicians often prescribe medications to manage specific autonomic and motor deficits:
Non-pharmacological interventions are vital for patients living with Multiple Systems Atrophy. Physical therapy is essential to improve gait, balance, and core strength to reduce the frequency of falls. Occupational therapy focuses on adapting the home environment to ensure safety, while speech therapy is critical for patients experiencing dysarthria or swallowing difficulties.
Because Multiple Systems Atrophy affects multiple body systems, a multidisciplinary approach is necessary. Your care team should ideally include a neurologist (preferably a movement disorder specialist), a urologist, a cardiologist, a physical therapist, and a speech-language pathologist. With 911 people living with Multiple Systems Atrophy in the DiseaseMaps.org community, sharing experiences with others can provide invaluable practical insights into navigating these specialist interactions.
Research is ongoing, with several clinical trials investigating potential disease-modifying therapies. Current studies are exploring neuroprotective agents and immunotherapies aimed at slowing the progression of Multiple Systems Atrophy. Patients are encouraged to consult clinicaltrials.gov to see if they meet the criteria for current research opportunities.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice; please consult your physician for personalized treatment decisions.